Skip to Content

MYLAN 2264 MYLAN 2264 (Terazosin Hydrochloride 2 mg)

Pill with imprint MYLAN 2264 MYLAN 2264 is Black / Purple, Capsule-shape and has been identified as Terazosin Hydrochloride 2 mg. It is supplied by Mylan Pharmaceuticals Inc..

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2264 MYLAN 2264

Terazosin Hydrochloride

Imprint:
MYLAN 2264 MYLAN 2264
Strength:
2 mg
Color:
Black / Purple
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
silicon dioxide
D&C Red No. 28
D&C Red No. 33
FD&C Blue No. 1
gelatin
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
titanium dioxide
ferrosoferric oxide
ammonia
propylene glycol
dimethicone
shellac
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0937 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide